Clinical Scenario

This protocol applies to adults with symptomatic varicose veins of the lower extremities in whom there is no truncal vein reflux. An initial course of conservative therapy has been completed but has not produced adequate symptom control.

Prior Therapy & Reason for Escalation

Previous treatment: Conservative therapy — including compression therapy, venotonic medications, lifestyle changes, and weight loss where applicable.

Goals not reached: Sufficient reduction in leg discomfort and a meaningful decrease in edema volume. Failure to reach these targets is the indication for moving to the next structured treatment step.

Next-Step Approach

For this patient group, the evidence-based protocol involves an interventional procedure combined with continued conservative management. The specific intervention, its full sequencing, and accompanying measures are detailed in the complete structured protocol.

Treatment Goals

Clinical targets at follow-up include a meaningful reduction in residual varicose veins and measurable improvement in symptoms — evaluated using the Venous Clinical Severity Score (VCSS) — at 8 weeks after treatment.

References

DOI: 10.1016/j.jscai.2025.103729

For patients with symptomatic varicose veins without truncal vein reflux, the SCAI guideline panel suggests foam sclerotherapy plus conservative management rather than conservative management alone (conditional recommendation, very low certainty of evidence).
For patients with symptomatic varicose veins without truncal vein reflux, the SCAI guideline panel suggests phlebectomy plus conservative management rather than conservative management alone (conditional recommendation, very low certainty of evidence).
Two RCTs comparing polidocanol 1% vs placebo found that treatment was associated with fewer residual varicose veins (RR, 0.19; 95% CI, 0.13-0.29) and an improvement in symptoms at 8 weeks (VCSS MD, 3.25 lower; 95% CI, 3.9-2.6).

View source ↗

Symptomatic Varicose Veins Without Truncal Vein Reflux: What to Do When Conservative Therapy Has Not Controlled Symptoms